Chen N - Search Results

1

Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer.

Yang Y, Pan J, Chen N, Guo Y, Huang X, Wu Y, Leaw S, Bai F, Wang Y, Zhao N, Tang B, Barnes G. Yang Y, et al. Among authors: chen n. Head Neck. 2024 Apr 26. doi: 10.1002/hed.27785. Online ahead of print. Head Neck. 2024. PMID: 38671587

2

Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).

Yang Y, Pan J, Wang H, Zhao Y, Qu S, Chen N, Chen X, Sun Y, He X, Hu C, Lin L, Yu Q, Wang S, Wang G, Lei F, Wen J, Yang K, Lin Z, Guo Y, Chen S, Huang X, Wu Y, Liang L, Chen C, Bai F, Ma X, Zhang Y, Leaw S, Zhang L, Fang W. Yang Y, et al. Among authors: chen n, chen s, chen c, chen x. Cancer Cell. 2023 Jun 12;41(6):1061-1072.e4. doi: 10.1016/j.ccell.2023.04.014. Epub 2023 May 18. Cancer Cell. 2023. PMID: 37207654 Free article. Clinical Trial.

3

Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.

Liao W, He J, Gou Q, Duan B, Ai P, Liu L, Li Y, Ren K, Yao M, Chen N. Liao W, et al. Among authors: chen n. Head Neck. 2021 Aug;43(8):2423-2433. doi: 10.1002/hed.26706. Epub 2021 May 3. Head Neck. 2021. PMID: 33939262 Free PMC article.

4

First-line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta-analysis and cost-effectiveness analysis.

Han J, Zeng N, Tian K, Liu Z, She L, Wang Z, He J, Chen N. Han J, et al. Among authors: chen n. Head Neck. 2023 Sep;45(9):2246-2258. doi: 10.1002/hed.27452. Epub 2023 Jul 12. Head Neck. 2023. PMID: 37435624

5

Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study.

Tao CJ, Yi JL, Chen NY, Ren W, Cheng J, Tung S, Kong L, Lin SJ, Pan JJ, Zhang GS, Hu J, Qi ZY, Ma J, Lu JD, Yan D, Sun Y. Tao CJ, et al. Radiother Oncol. 2015 Jun;115(3):407-11. doi: 10.1016/j.radonc.2015.05.012. Epub 2015 May 26. Radiother Oncol. 2015. PMID: 26025546

6

The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT.

Gou X, Duan B, Shi H, Qin L, Xiao J, Chen N. Gou X, et al. Among authors: chen n. Head Neck. 2020 Jan;42(1):85-92. doi: 10.1002/hed.25986. Epub 2019 Oct 24. Head Neck. 2020. PMID: 31650657 Free PMC article.

7

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.

Deng L, Lei Q, Wang Y, Wang Z, Xie G, Zhong X, Wang Y, Chen N, Qiu Y, Pu T, Bu H, Zheng H. Deng L, et al. Among authors: chen n. Oncotarget. 2017 Oct 6;8(65):108712-108725. doi: 10.18632/oncotarget.21561. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312562 Free PMC article.

8

Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic Chemotherapy.

Liao W, He J, Gou Q, Duan B, Liu L, Ai P, Li Y, Ren K, Chen N. Liao W, et al. Among authors: chen n. Cancer Manag Res. 2020 Oct 15;12:10211-10219. doi: 10.2147/CMAR.S276286. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116875 Free PMC article.

9

Long-term outcomes of metastasis-directed stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma.

Yang J, Liao W, Su S, Zeng N, Zhang S, He J, Chen N. Yang J, et al. Among authors: chen n. Cancer Med. 2023 Dec 26;13(1):e6764. doi: 10.1002/cam4.6764. Online ahead of print. Cancer Med. 2023. PMID: 38148586 Free PMC article.

10

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma.

Han J, Lan X, Tian K, Shen X, He J, Chen N. Han J, et al. Among authors: chen n. Front Public Health. 2023 Jan 26;10:1086393. doi: 10.3389/fpubh.2022.1086393. eCollection 2022. Front Public Health. 2023. PMID: 36777769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,189 results

Search Page